UBS Oncology Impact Fund
Europe, Zurich, Switzerland, Zürich
Description
UBS Oncology Impact Fund
Investor Profile
UBS Oncology Impact Fund has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Biotechnology, Oncology, Therapeutics.
Stage Focus
- Series A (60%)
- Series B (40%)
Country Focus
- United States (60%)
- Canada (40%)
Industry Focus
- Biotechnology
- Oncology
- Therapeutics
- Health Care
- Pharmaceutical
- Medical
- Alternative Medicine
- Information Technology
- Biopharma
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cg id='b'%3e%3cpath id='a' stroke='%23000' stroke-width='2' d='M-6-25H6m-12 3H6m-12 3H6'/%3e%3cuse xlink:href='%23a' y='44'/%3e%3c/g%3e%3cpath stroke='%23fff' d='M0 17v10'/%3e%3ccircle r='12' fill='%23cd2e3a'/%3e%3cpath fill='%230047a0' d='M0-12A6 6 0 0 0 0 0a6 6 0 0 1 0 12 12 12 0 0 1 0-24z'/%3e%3c/g%3e%3cg transform='rotate(-123.69)'%3e%3cuse xlink:href='%23b'/%3e%3cpath stroke='%23fff' d='M0-23.5v3M0 17v3.5m0 3v3'/%3e%3c/g%3e%3c/svg%3e)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
